1. Increased neutrophil-to-lymphocyte ratio is a novel marker for nutrition, inflammation and chemotherapy outcome in patients with locally advanced and metastatic esophageal squamous cell carcinoma
   Yu Sato et al, 2017, Biomedical Reports CrossRef
2. The pretreatment neutrophil‐lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta‐analysis
   Guang‐Tao Min et al, 2018, Clinical Transplantation CrossRef
3. Innovative Blood Tests for Hepatocellular Carcinoma: Liquid Biopsy and Evaluation of Systemic Inflammatory Reaction
   Ilze Strumfa et al, 2018, Hepatocellular Carcinoma - Advances in Diagnosis and Treatment CrossRef
4. Preoperative neutrophil-to-lymphocyte ratio and tumor-related factors to predict microvascular invasion in patients with hepatocellular carcinoma
   Yanlong Yu et al, 2017, Oncotarget CrossRef
5. Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma
   Dong Wook Jekarl et al, 2019, PLOS ONE CrossRef
6. Glasgow Prognostic Score and modified Glasgow Prognostic Score and survival in patients with hepatocellular carcinoma: a meta-analysis
   Lingling Lu et al, 2021, BMJ Open CrossRef
7. Comparison Between Neutrophil–Lymphocyte Ratio and Systemic Immune-Inflammation Index as Predictors of One-Year Survival in Patients with Untreated Advanced Hepatocellular Carcinoma
   Irsan Hasan et al, 2023, Journal of Gastrointestinal Cancer CrossRef
8. Profiles Combining Muscle Atrophy and Neutrophil-to-Lymphocyte Ratio Are Associated with Prognosis of Patients with Stage IV Gastric Cancer
   Kota Shigeto et al, 2020, Nutrients CrossRef
9. Prognostic Significance of the Imaging Parameters of Adipose Tissue and Bone Marrow on F-18 Fluorodeoxyglucose PET/CT in Patients with Malignant Melanoma
   Ju Ha Lee et al, 2019, Journal of the Korean Society of Radiology CrossRef
10. Immunological inflammatory biomarkers as prognostic predictors for advanced hepatocellular carcinoma
    M. Nakano et al, 2021, ESMO Open CrossRef
11. Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis
    Bo Li et al, 2018, Clinica Chimica Acta CrossRef
12. The decreased risk of hepatocellular carcinoma in hepatitis B virus-related cirrhotic portal hypertension patients after laparoscopic splenectomy and azygoportal disconnection
    Tian-Ming Gao et al, 2023, Surgical Endoscopy CrossRef
13. Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma
    Hikmet Akkiz et al, 2021, International Journal of Clinical Practice CrossRef
14. Predictive value of the preoperative neutrophil-to-lymphocyte ratio for the development of hepatocellular carcinoma in HBV-associated cirrhotic patients after splenectomy
    Zhaoqing Du et al, 2018, PLOS ONE CrossRef
15. Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases
    Sean M. McDermott et al, 2018, Journal of Surgical Research CrossRef
16. Immunological consequences following splenectomy in patients with liver cirrhosis
    Yusuke Hirakawa et al, 2019, Experimental and Therapeutic Medicine CrossRef
17. A new model based on gamma-glutamyl transpeptidase to lymphocyte ratio and systemic immune-inflammation index can effectively predict the recurrence of hepatocellular carcinoma after liver transplantation
    Weiqi Zhang et al, 2023, Frontiers in Oncology CrossRef
18. Value of the preoperative neutrophil‐to‐lymphocyte ratio as a prognostic factor for long‐term survival in postoperative esophageal squamous cell carcinoma patients
    Guang‐wen Xu et al, 2018, Thoracic Cancer CrossRef
19. Elevated neutrophil‑to‑lymphocyte ratio is associated with nutritional impairment, immune suppression, resistance to S‑1 plus cisplatin, and poor prognosis in patients with stage?IV gastric cancer
    Kenji Gonda et al, 2017, Molecular and Clinical Oncology CrossRef
20. Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis
    Yongzhao Zhao et al, 2017, Oncotarget CrossRef
21. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma
    Mian-Tao Wu et al, 2019, BMC Cancer CrossRef
22. Clinical characteristics and prognostic factors of liver cirrhosis patients with systemic inflammatory response syndrome
    Danhong Yang et al, 2017, Hepatology Research CrossRef
23. The paradoxical changes of membrane and soluble herpes virus entry mediator in hepatocellular carcinoma patients
    Qiyi Zhao et al, 2017, Journal of Gastroenterology and Hepatology CrossRef
24. The Pretransplant Neutrophil-Lymphocyte Ratio as a New Prognostic Predictor After Liver Transplantation For Hepatocellular Cancer: a Systematic Review and Meta-analysis
    Zheng-Guang Xu et al, 2018, Biomarkers in Medicine CrossRef
25. C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma
    Aslı Suner et al, 2019, Oncology CrossRef